Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti‐CC chemokine receptor 4 antibody for the treatment of adult T‐cell leukaemia/lymphoma. Issue 1 (14th July 2015) - Shiratori, Souichi; Ohhigashi, Hiroyuki; Ito, Shinichi; Kudo, Kazuhiro; Adachi, Maki; Minamimoto, Toshiyuki; Kato, Junji; Osai, Yasue; Tsutsumi, Yutaka; Teshima, Takanori